Drooid Logo
Back to story perspectives

Full Breakdown

Unraveling the Genetic Landscape of Epilepsy

3/10/2026, 11:22:24 AM

Overview of Genetic Research in Epilepsy

A recent mini-review published in *Genomic Psychiatry* synthesizes findings from extensive genetic research on common epilepsies, revealing that thousands of small-effect genetic variants contribute to these disorders, many of which remain undetected. The study, led by Dr. Olav B. Smeland from the Centre for Precision Psychiatry at Oslo University Hospital, emphasizes the complexity of epilepsy, which affects approximately 50 million people worldwide and is characterized by various seizure disorders.

Insights from Twin Studies

Historical twin studies have provided foundational insights into the heritability of epilepsy. For instance, concordance rates for genetic generalized epilepsy reached 77% in identical twins compared to 35% in fraternal twins, while focal epilepsy showed lower rates of 40% and 3%, respectively. These findings underscore the significant genetic component in the development of epilepsy, particularly in its generalized form.

Genetic Variants and Their Implications

The review highlights the role of both common and rare genetic variants in epilepsy risk. A study involving 13,420 epilepsy cases found that genetic generalized epilepsy exhibited the highest burden of copy number variants, with recurrent deletions at the 15q13.3 locus identified as a significant risk factor. Additionally, the largest genome-wide association study to date identified 26 genome-wide significant loci, predominantly linked to genetic generalized epilepsy, indicating a disparity in genetic architecture between epilepsy subtypes.

Genetic Convergence and Pleiotropy

A notable finding from the review is the genetic convergence between monogenic and polygenic forms of epilepsy. Ten of the prioritized genes from the identified loci are established monogenic epilepsy genes, suggesting shared biological pathways. The review also discusses genetic pleiotropy, where variants influence multiple traits, revealing a genetic correlation between epilepsy and psychiatric disorders such as schizophrenia and major depression.

Limitations and Future Directions

Despite the advancements, the review cautions against the premature use of polygenic risk scores for routine clinical decision-making, particularly due to the lack of diversity in study populations—over 92% of cases in the largest study were of European ancestry. The authors advocate for larger, more diverse sample sizes to enhance the generalizability of findings. They also emphasize the need for integrated approaches combining genetic data with clinical and cognitive variables to improve predictive models for epilepsy.

Official Statements & Responses

Dr. Smeland noted, "The genetic signal is there, the tools are improving, and the returns on investment in larger, more diverse samples are clear." He also highlighted the importance of broadening ancestral diversity in study populations to ensure equitable implementation of genetic findings.

Verbatim Quotes

  • “Understanding these shared genetic foundations may eventually help identify epilepsy patients at elevated risk for psychiatric comorbidities.” — Dr. Olav B. Smeland, Centre for Precision Psychiatry
  • “We are still at an early stage of genetic discovery for common epilepsies,” — Julian Fuhrer, Centre for Precision Psychiatry

The mini-review by Dr. Smeland and colleagues represents a significant step in understanding the genetic underpinnings of common epilepsies, paving the way for future research and potential clinical applications.